{
    "Case ID": "008102",
    "Crime_Name": [
        "Judicial Review Application"
    ],
    "Crime_Type": [
        "Violations of Immigration Regulations"
    ],
    "Violation_Type": [],
    "Legal_Issue": [
        "Whether applicants can file reply evidence in a judicial review application under the Federal Court Rules"
    ],
    "Governing_Law": [],
    "Application_Facts": [
        "Applicants received new evidence from Apotex regarding a synthetic process, which is critical to determining whether processes are identical"
    ],
    "Decision_Outcome": [
        "Motion allowed; applicants permitted to file reply evidence within seven days"
    ],
    "Remedy_Requested": [
        "Permission to file reply evidence"
    ],
    "Court_Ruling": [
        "Court granted leave for applicants to submit reply evidence, with respondents allowed to cross-examine"
    ],
    "Claimant_Status": [],
    "Defendant_Behavior": [
        "Apotex disclosed new evidence about a synthetic process during the judicial review proceedings"
    ],
    "Grounds_for_Claim": [
        "Need to respond to new evidence that impacts the core issue of process identity"
    ],
    "Legal_Standard": [
        "Courts have discretion to allow reply evidence if it serves justice, assists the court, and does not prejudice the other party"
    ],
    "Assessment_Factor": [
        "Relevance of new evidence, necessity for fair adjudication, potential prejudice to respondents"
    ],
    "Applicable_Legislation": [],
    "Procedural_Issue": [
        "Filing of reply evidence in judicial review under Federal Court Rules"
    ],
    "Review_Standard": [],
    "Credibility_Assessment": [],
    "Evidence_Used": [
        "New evidence from Apotex on synthetic process; potential reply evidence from applicants"
    ],
    "Legal_Provision_Cited": [],
    "Application_Basis": [
        "Federal Court Rules discretion to permit reply evidence"
    ],
    "Evidence_Assessed": [
        "New evidence on synthetic process submitted by Apotex"
    ],
    "Relief_Sought": [
        "Leave to file reply evidence"
    ],
    "Governing_Rule": [
        "Federal Court Rules"
    ],
    "Evidentiary_Deficiency": [],
    "Outcome": [
        "Applicants may file reply evidence within seven days; respondents may cross-examine"
    ],
    "Decisional_Body": [
        "Federal Court"
    ],
    "Harm_Assessment": [],
    "Cause_Description": [
        "Dispute over whether processes disclosed by Apotex match those alleged in a drug compliance notice"
    ],
    "Evidence_Handling": [
        "Court permits submission of reply evidence with safeguards including cross-examination"
    ],
    "Legal_Provision_Violated": [],
    "Evidence_Issues": [
        "Introduction of new evidence by Apotex necessitating potential reply evidence"
    ],
    "Residency_Compliance": [],
    "Misrepresentation_Element": [],
    "Legal_Provision": [],
    "Jurisdictional_Issue": [],
    "Evidence_Assessment": [
        "Court assessed that reply evidence would assist in resolving the central technical issue without unfair prejudice"
    ],
    "Decision_Rationale": [
        "Allowing reply evidence serves the interests of justice, aids the court, and can be managed without prejudice through procedural safeguards"
    ],
    "Country_of_Origin": [],
    "Decision_Making_Body": [
        "Federal Court"
    ],
    "Evidentiary_Issues": [
        "Timing and admissibility of reply evidence in judicial review"
    ],
    "Legal_Standard_Applied": [
        "Discretionary fairness standard under Federal Court Rules for admitting reply evidence"
    ]
}